Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
20.90    -0.10 (-0.48%)
Bid:
20.90
Ask:
21.90
Spread: 1.00 (4.785%)
Market Cap: €115.95b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA offer modification

9 Jan 2025 17:48

RNS Number : 8202S
Banco Bilbao Vizcaya Argentaria SA
09 January 2025
Β 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in accordance with the provisions of the Securities Market legislation, hereby communicates, at the request of the Spanish Securities Market Commission (CNMV) and in accordance with the provisions of Article 234 of Law 6/2023, of March 17, on Securities Markets and Investment Services, the following:

Β 

INSIDE INFORMATION

Β 

In relation to the voluntary tender offer launched by BBVA for the entire share capital of Banco de Sabadell, S.A. ("Banco Sabadell" or the "Target Company") (the "Offer"), for which the prior announcement was published as inside information on May 9, 2024 and the request for authorisation was submitted to the CNMV on May 24, 2024 and gave leave to proceed on June 11, 2024, BBVA informs that it has decided to modify the Offer by reducing the minimum acceptance condition provided in the prior announcement, which implies a more favorable treatment for its recipients, in accordance with Article 31.1 of Royal Decree 1066/2007.

The aforementioned minimum acceptance condition, which initially required the acceptance of the Offer by at least 2,720,654,746 shares of the Target Company, representing 50.01 percent of its share capital, is now reduced so that it requires the Offer to be accepted for a number of shares that allows BBVA to acquire at least more than half of the effective voting rights of Banco Sabadell at the end of the Offer acceptance period (therefore excluding the treasury shares that the Target Company may hold at that time).

As of the date of this communication, the total share capital with voting rights amounts to 5,361,450,912 ordinary shares (5,361,450 effective voting rights), considering that Banco Sabadell's share capital is represented by a total of 5,440,221,447 ordinary shares (5,440,221 voting rights) and that it holds 78,770,535 treasury shares (as stated in Banco Sabadell's Universal Registration Document posted on the CNMV's website on May 23, 2024), whose voting rights are suspended in accordance with Article 148(a) of the Spanish Companies Act. Therefore, assuming that all such treasury shares remain as such at the end of the Offer acceptance period, the reduced minimum acceptance condition will be deemed fulfilled if the Offer is accepted for at least 2,680,726,000 shares of Banco Sabadell (2,680,726 voting rights), which would represent half plus one of Banco Sabadell's effective voting rights at that time.

The above notwithstanding, if Banco Sabadell's treasury shares vary by the end of the acceptance period, the condition will be deemed fulfilled if the Offer is accepted for the number of shares necessary to acquire more than 50 percent of the effective voting rights at that time, thus excluding the suspended voting rights corresponding to the treasury shares held by Banco Sabadell on that date.

In the event of a positive outcome of the Offer, BBVA will seek the redemption of Banco Sabadell's treasury shares at the end of the acceptance period at the first General Shareholders' Meeting of Banco Sabadell, reducing the share capital and locking up those shares in the meantime.Β 

The fulfillment of this reduced minimum acceptance condition, under the described terms, will make applicable the exception to the obligation to launch a mandatory tender offer in accordance with Article 8(f) of Royal Decree 1066/2007, to the extent that the Offer would have been accepted for shares representing, at least, 50 percent of the effective voting rights to which it was addressed.

BBVA will submit to the CNMV the documentation related to the improved terms of the Offer in accordance with Articles 17 and 20 of Royal Decree 1066/2007.

Β 

Β 

Madrid, January 9, 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCSSIFWUEISELF
Date   Source Headline
20th Dec 20187:00 amRNSEstrategy automobile financing business in Chile
17th Dec 20181:03 pmRNSPublication of approved ECP Information Memorandum
28th Nov 20185:17 pmRNSComposition of the Board of Directors
5th Nov 20187:00 amRNS2018 Stress Test by European Banking Authority
30th Oct 20187:00 amRNS3Q18 Results Report
30th Oct 20187:00 amRNS3Q18 Results Presentation
30th Oct 20187:00 amRNS3Q18 Results Press Release
22nd Oct 20185:15 pmRNS3rd Quarter Results Presentation Announcement
10th Oct 20185:09 pmRNSTransfer of Real Estate business to Cerberus
27th Sep 20187:00 amRNSDividend October 2018
26th Sep 20183:43 pmRNSOrganizational Changes
18th Sep 20186:17 pmRNSIssue of preferred securities contingently conv.
18th Sep 20188:38 amRNSOffer of securities contingently convertible
30th Jul 20185:00 pmRNSInterim Report BBVA Group June 2018
27th Jul 20187:00 amRNS2Q18 Results Press Release
27th Jul 20187:00 amRNS2Q18 Results Report
27th Jul 20187:00 amRNS2Q18 Results Presentation
23rd Jul 20185:49 pmRNS2Q18 Results Presentation Announcement
9th Jul 20187:00 amRNScompleted sale of its shareholding stake in Chile
27th Jun 20186:20 pmRNSChanges on Board's Committees
4th Jun 20188:26 amRNSSupplemental to the Offering Circular - GMTN
1st Jun 201811:52 amRNSInterim Consolidated Financial Statements
1st Jun 201811:39 amRNSPost Stabilisation Notice
31st May 201812:08 pmRNSMoody's upgrades BBVA's rating
29th May 20184:39 pmRNSGMTN Programme - Final Terms
23rd May 20185:40 pmRNSMREL Requirement
3rd May 201811:12 amRNSPre Stabilisation Notice
30th Apr 20184:58 pmRNSSupplement to the Offering Circular - GMTN
30th Apr 20188:20 amRNS2017 Audited Financial Statements
27th Apr 20187:00 amRNS1Q18 Results Report
27th Apr 20187:00 amRNS1Q18 Results Press Release
27th Apr 20187:00 amRNS1Q18 Results Presentation
26th Apr 20181:06 pmRNS2017 Form 20-F
25th Apr 20184:23 pmRNSSupplement to the Offering Circular - Green Bonds
23rd Apr 20187:40 amRNS1Q18 Results Presentation Announcement
12th Apr 20186:28 pmRNSDBRS upgrades BBVA's rating
9th Apr 201810:11 amRNSPost-Stabilisation Notice - BBVA
9th Apr 20188:25 amRNSS&P upgrades BBVA's rating
16th Mar 20183:45 pmRNSAgreements of shareholders general meetings
13th Mar 20187:00 amRNSEarly expiration
12th Mar 201812:19 pmRNSGMTN Programme
27th Feb 20188:18 amRNSPre-Stabilisation Notice - BBVA
16th Feb 20184:00 pmRNSNew translation of the 2018 AGM agenda
14th Feb 20183:05 pmRNSGMTN Programme-Supplement to the Offering Circular
14th Feb 20189:23 amRNSBBVA Group Annual Report 2017
14th Feb 20187:41 amRNS2018 AGM Proposed Resolutions
13th Feb 20187:00 amRNSFinal Dividend Calendar 2017
13th Feb 20187:00 amRNS2018 Annual General Meeting Call
7th Feb 20182:14 pmRNSPublication of approved ECP Supplement
1st Feb 20187:09 amRNS4Q17 Results Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.